Genomics Market Research Report 2025: Innovations Are Accelerating The Transition To Faster Diagnostics, Scalable Biomanufacturing, And Precision Therapies
Dublin, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The "Genomics" report has been added to ResearchAndMarkets's offering.
Genomic innovation is accelerating the transition to faster diagnostics, scalable biomanufacturing, and precision therapies.
Genomics report delivers a comprehensive analysis of the technologies redefining molecular healthcare. The report highlights automated DNA extraction, metagenomic pathogen detection, genome-edited iPSC therapies, plasmid DNA extraction kits, and isothermal DNA amplification, each positioned to address critical challenges in clinical reliability, decentralized testing, and therapeutic accessibility.
Using the analyst's proprietary Tech Foresights platform, the report examines innovation drivers, challenges, patent leadership, and real-world applications, providing essential strategic guidance for R&D leaders and decision-makers.
Report Scope
- Sector innovation radar chart identifies key disruptive forces within the genomics theme High-impact innovations are ranked in the genomics theme by their projected impact and include their supplementary patent details Innovations deep-dive gives an overview and highlights patent indicators, key enterprise and startup/university innovators, and market buzz of select innovations Methodology details on how the innovations and companies are listed into select categories
Reasons to Buy
- The analyst's FutureTech Series Reports are aimed at capturing futuristic technologies which have the potential to disrupt tomorrow. These technologies are constantly changing, adapting, and progressing to enable a paradigm shift in our daily lives. The awareness, knowledge, and expertise of these topics help transform business models and strategic thinking with an in-depth understanding of megatrends that can directly influence patenting, collaboration, acquisition, and investment decisions.
Key Topics Covered:
1. Executive summary
2. Latest innovations in Genomics theme: Radar chart identifying key disruptive forces within the Genomics theme and high-impact innovations with supplementary patent and innovator details
3. Deep dive into five prominent innovations: Definition, application areas, drivers and challenges, patenting activity, leading enterprise and startup/university innovators, and current landscape
4. Tech Foresights Methodology
5. Glossary
6. Further Reading
7. Contact the Publisher
Companies Featured
- 10X Genomics 3PBIOVIAN Abbott Laboratories Addgene Amerigo Scientific Amped Arima Genomics Basilard Biotech Becton Dickinson Butterfly Network Cambrian Bioworks CD Bioparticles Clarius Clear Labs Cleerly Coyote Bioscience Creative Bioarray Delve Bio Duke University Elekta Fujifilm G2M General Electric Ginkgo Bioworks Hangzhou Bigfish Bio-tech Harvard University Heligenics IBM Illumina IST-Innuscreen iXgene Johnson & Johnson Karius Made Scientific MDHC Life Technologies MuscleSound Neogen NovelBio Omega Bio-Tek Philips Pluristyx RefleXion RNA Connect Samsung Group Siemens Sony Group Synplogen Thermo Fisher Tongli Biomedical United Imaging University of California University of Colorado University of Texas System Us2 Xeno Therapeutics Yourgene
For more information about this report visit
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment